102 related articles for article (PubMed ID: 35474410)
1. Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.
Mahmoudian RA; Fathi F; Farshchian M; Abbaszadegan MR
Mol Biotechnol; 2023 Mar; 65(3):350-360. PubMed ID: 35474410
[TBL] [Abstract][Full Text] [Related]
2. High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.
Portier I; Vanhoorelbeke K; Verhenne S; Pareyn I; Vandeputte N; Deckmyn H; Goldenberg DS; Samal HB; Singh M; Ivics Z; Izsvák Z; De Meyer SF
J Thromb Haemost; 2018 Mar; 16(3):592-604. PubMed ID: 29288565
[TBL] [Abstract][Full Text] [Related]
3.
Kovač A; Miskey C; Ivics Z
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834425
[TBL] [Abstract][Full Text] [Related]
4. AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells.
Ye L; Lam SZ; Yang L; Suzuki K; Zou Y; Lin Q; Zhang Y; Clark P; Peng L; Chen S
Nat Biomed Eng; 2024 Feb; 8(2):132-148. PubMed ID: 37430157
[TBL] [Abstract][Full Text] [Related]
5. Site-directed transposon integration in human cells.
Yant SR; Huang Y; Akache B; Kay MA
Nucleic Acids Res; 2007; 35(7):e50. PubMed ID: 17344320
[TBL] [Abstract][Full Text] [Related]
6. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy.
Liu G; Aronovich EL; Cui Z; Whitley CB; Hackett PB
J Gene Med; 2004 May; 6(5):574-83. PubMed ID: 15133768
[TBL] [Abstract][Full Text] [Related]
7. Generation of an inducible and optimized piggyBac transposon system.
Cadiñanos J; Bradley A
Nucleic Acids Res; 2007; 35(12):e87. PubMed ID: 17576687
[TBL] [Abstract][Full Text] [Related]
8. Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo.
Podetz-Pedersen KM; Vezys V; Somia NV; Russell SJ; McIvor RS
Hum Gene Ther; 2014 Nov; 25(11):955-65. PubMed ID: 25093708
[TBL] [Abstract][Full Text] [Related]
9. A transposon and transposase system for human application.
Hackett PB; Largaespada DA; Cooper LJ
Mol Ther; 2010 Apr; 18(4):674-83. PubMed ID: 20104209
[TBL] [Abstract][Full Text] [Related]
10. Preferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injection.
Bell JB; Podetz-Pedersen KM; Aronovich EL; Belur LR; McIvor RS; Hackett PB
Nat Protoc; 2007; 2(12):3153-65. PubMed ID: 18079715
[TBL] [Abstract][Full Text] [Related]
11. Regulated transposition of a fish transposon in the mouse germ line.
Fischer SE; Wienholds E; Plasterk RH
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6759-64. PubMed ID: 11381141
[TBL] [Abstract][Full Text] [Related]
12. An optimized polymeric delivery system for piggyBac transposition.
Meenakshi Sundaram DN; Bahadur K C R; Fu W; Uludağ H
Biotechnol Bioeng; 2024 May; 121(5):1503-1517. PubMed ID: 38372658
[TBL] [Abstract][Full Text] [Related]
13. Mage transposon: a novel gene delivery system for mammalian cells.
Tian J; Tong D; Li Z; Wang E; Yu Y; Lv H; Hu Z; Sun F; Wang G; He M; Xia T
Nucleic Acids Res; 2024 Mar; 52(5):2724-2739. PubMed ID: 38300794
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the piggyBac transposon using mRNA and insulators: toward a more reliable gene delivery system.
Bire S; Ley D; Casteret S; Mermod N; Bigot Y; Rouleux-Bonnin F
PLoS One; 2013; 8(12):e82559. PubMed ID: 24312663
[TBL] [Abstract][Full Text] [Related]
15. Sleeping Beauty Transposon-Mediated Asparaginase Gene Delivery by a Nanoparticle Platform.
Chang JH; Mou KY; Mou CY
Sci Rep; 2019 Aug; 9(1):11457. PubMed ID: 31391525
[TBL] [Abstract][Full Text] [Related]
16. Genomic features of recombinant CHO clones arising from transposon-based and randomized integration.
Huhn SC; Chang M; Jiang B; Tang X; Betenbaugh M; Du Z
J Biotechnol; 2023 Aug; 373():73-81. PubMed ID: 37271453
[TBL] [Abstract][Full Text] [Related]
17. Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach.
Lange S; Kuntze A; Wüstmann N; Reckers T; Humberg V; Dirks WG; Huss S; Vieler J; Schrader AJ; Bögemann M; Schlack K; Bernemann C
Biol Res; 2024 May; 57(1):21. PubMed ID: 38704600
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.
Hackett PB; Aronovich EL; Hunter D; Urness M; Bell JB; Kass SJ; Cooper LJ; McIvor S
Curr Gene Ther; 2011 Oct; 11(5):341-9. PubMed ID: 21888621
[TBL] [Abstract][Full Text] [Related]
19. Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines.
Rajendran S; Balasubramanian S; Webster L; Lee M; Vavilala D; Kulikov N; Choi J; Tang C; Hunter M; Wang R; Kaur H; Karunakaran S; Sitaraman V; Minshull J; Boldog F
Biotechnol Bioeng; 2021 Jun; 118(6):2301-2311. PubMed ID: 33704772
[TBL] [Abstract][Full Text] [Related]
20. Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase.
Gersbach CA; Gaj T; Gordley RM; Mercer AC; Barbas CF
Nucleic Acids Res; 2011 Sep; 39(17):7868-78. PubMed ID: 21653554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
